Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Akebia Therapeutics, Inc. | akba-ex321_16.htm |
| EX-31.2 - EX-31.2 - Akebia Therapeutics, Inc. | akba-ex312_8.htm |
| EX-31.1 - EX-31.1 - Akebia Therapeutics, Inc. | akba-ex311_17.htm |
| EX-23.1 - EX-23.1 - Akebia Therapeutics, Inc. | akba-ex231_654.htm |
| EX-10.63 - EX-10.63 - Akebia Therapeutics, Inc. | akba-ex1063_589.htm |
| EX-10.62 - EX-10.62 - Akebia Therapeutics, Inc. | akba-ex1062_588.htm |
| EX-4.6 - EX-4.6 - Akebia Therapeutics, Inc. | akba-ex46_587.htm |
| 10-K - 10-K - Akebia Therapeutics, Inc. | akba-10k_20191231.htm |
Exhibit 21.1
SUBSIDIARIES OF THE REGISTRANT
|
Name |
|
|
|
Jurisdiction of Organization |
|
Akebia Therapeutics Securities Corporation |
|
|
|
Massachusetts |
|
Akebia Europe Limited |
|
|
|
Ireland |
|
Keryx Biopharmaceuticals, Inc. |
|
|
|
Delaware |
|
ACCESS Oncology, Inc. |
|
|
|
Delaware |
|
AOI Pharma, Inc. |
|
|
|
Delaware |
|
AOI Pharmaceuticals, Inc. |
|
|
|
Delaware |
|
Online Collaborative Oncology Group, Inc. |
|
|
|
Delaware |
|
Accumin Diagnostics, Inc. |
|
|
|
Delaware |
|
Neryx Biopharmaceuticals, Inc. |
|
|
|
Delaware |
|
Keryx Biopharma UK Ltd. |
|
|
|
United Kingdom |
|
Keryx Israel, Ltd. |
|
|
|
Israel |
|
Keryx Biomedical Technologies, Ltd. |
|
|
|
Israel |
Exhibit 21.1